Comic: Stock Market Weighs Soaring COVID-19 Cases, Progress On Vaccines

0
409


By Jesse Cohen

Investing.com – Stocks on ended lower on Friday, as investors weighed the worrying increase of new COVID-19 cases against apparent progress on vaccines.

The fell 219 points, or 0.8%, to close the day at 29,263. The S&P 500 shed 0.7% to settle at 3,557, while the ended the session down 0.4% at 11,854.

Article continues below Advertisement...

For the week, the Dow and S&P 500 lost 0.7% and 0.8%, respectively, to post their first weekly decline in three weeks. The tech-heavy Nasdaq however managed to score a gain of 0.2% over that time frame.

Coronavirus cases are soaring across the U.S., leading a handful of states and cities to reimpose social distancing restrictions to try to slow the rapid spread of the disease ahead of the winter season.

Public health professionals are also urging people to give up on holiday gatherings, with the Thanksgiving holiday just a few days away.

The biggest question in the right now is whether the negative headlines of soaring virus cases and renewed lockdowns will be enough to derail the positive developments seen on the vaccine front.

Good news about potential vaccines from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) had helped push the Dow and S&P 500 to a record high earlier in the week.

To see more of Investing.com’s weekly comics, visit: http://www.investing.com/analysis/comics

Source: Investing.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here